New research suggests rising heat might trigger earlier births

Date:

Share this article:

Del denne artikel:

Scientists uncover molecular signals that may explain why hotter days raise the risk of preterm delivery.

As global temperatures rise, doctors have observed a troubling pattern: more babies are being born too early following periods of unusually hot weather.

A new study from Emory University adds important detail to that picture, pointing to subtle chemical shifts in the bloodstream that may help explain why.

The research, published in Science Advances, focuses on biological markers that have long been difficult to pinpoint.

While earlier work hinted that heat can affect inflammation, oxidative stress and cardiovascular strain in pregnancy, the precise mechanisms have remained largely unclear.

Also read: New study: Even a few cigarettes a day can damage the heart

Following heat exposure through the blood

To explore these hidden pathways, the team analyzed blood samples from 215 pregnant women in metropolitan Atlanta.

The participants experienced varying levels of heat exposure based on where they lived, allowing researchers to compare environmental conditions with molecular activity in the body.

Using metabolomic profiling, a technique that maps thousands of small molecules circulating in the blood, the scientists identified a set of amino acids that shifted noticeably during periods of higher temperatures.

Among them were methionine, proline, citrulline and pipecolate, compounds essential to managing stress responses and energy production.

Also read: Lab-grown cardiac patch shows early promise

According to lead researcher Donghai Liang, these molecular changes resembled the patterns observed in mothers who later delivered prematurely, suggesting a shared biological route connecting heat exposure and elevated preterm birth risk.

Implications for maternal health in a warming world

Preterm birth remains one of the leading causes of infant illness and mortality, yet many of its root causes are still poorly understood.

The Emory findings offer a rare window into the early biological shifts that may increase vulnerability during pregnancy.

Researchers say the work could eventually support the development of early-warning biomarkers, signals in the blood that help clinicians identify pregnancies most at risk when temperatures rise.

Also read: Researchers uncover why some people are simply better at remembering faces

Although more studies are needed, especially across larger and more diverse populations, the results underscore the urgency of protecting maternal health as extreme heat becomes more common.

Sources: News Medical, and Science Advances.

Also read: Researchers test new nasal drops that may help fight aggressive brain tumors

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

A single brain protein may drive aging, and old mice bounced back in about a month

The clue researchers chased sits in a small corner of the brain that quietly steers almost everything else.

The most effective quit-smoking tool has been found

The biggest evidence review yet on how to stop smoking has a clear answer, and it is not the one most doctors still reach for first.

Promising lung cancer drug hits major setback just days before FDA decision

A promising treatment for one of the deadliest lung cancers has hit a setback that experts did not see coming.

Your eyeliner and mascara may be more dangerous than you think, data shows

The familiar tubes sitting on your bathroom shelf are sending people to the emergency room more often than you would guess.

A single brain protein may drive aging, and old mice bounced back in about a month

The clue researchers chased sits in a small corner of the brain that quietly steers almost everything else.

The most effective quit-smoking tool has been found

The biggest evidence review yet on how to stop smoking has a clear answer, and it is not the one most doctors still reach for first.

Promising lung cancer drug hits major setback just days before FDA decision

A promising treatment for one of the deadliest lung cancers has hit a setback that experts did not see coming.